Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Latest Health Innovations from Nutra Pharma Corporation

  • Broadcast in Health
Nancy T Ferrari

Nancy T Ferrari

×  

Follow This Show

If you liked this show, you should follow Nancy T Ferrari.
h:124767
s:1745263
archived

Innovative Health News will be discussed as I present Rik J. Deitsch, President, Chief Executive Officer and a Director of Nutra Pharma Corporation since November 7, 2002. From February 1998 through November 2002, Mr. Deitsch served as the President of NDA Consulting Inc., a biotechnology research group that provided consulting services to the pharmaceutical industry. NDA Consulting specialized in the research of peptides derived from Cone Snail venom, Cobra venom and Gila Monster venom. Mr. Deitsch holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted clinical and laboratory research in collaboration with scientists at Duke University Medical Center and the Cleveland Clinic .

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled